Literature DB >> 15628841

Solution structure of human survivin and its binding interface with Smac/Diablo.

Chaohong Sun1, David Nettesheim, Zhihong Liu, Edward T Olejniczak.   

Abstract

NMR studies of the antiapoptotic protein survivin have been used to determine the homodimer interface of the protein in solution and to identify residues of the protein that interact with Smac/Diablo. In solution, survivin(1-120) forms a bow-tie-shaped dimer whose interface is composed of its N-terminal residues as well as residues connecting its BIR domain to the C-terminal alpha helix. The solution structure resolves the controversy regarding the two possible dimer interfaces for survivin observed in X-ray crystal structures. The structural basis for the interaction between survivin and Smac/Diablo was also investigated. When Smac/Diablo or N-terminal Smac/Diablo peptide analogues are added to a solution of survivin, specific residues near alpha4 and beta3 are perturbed. NMR experiments indicate that the peptides bind across the third beta-strand of survivin in a manner similar to the way Smac/Diablo peptides bind to the BIR3 domain of X-linked IAP (XIAP).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15628841     DOI: 10.1021/bi0485171

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  40 in total

1.  Association between survivin -31G > C promoter polymorphism and cancer risk: a meta-analysis.

Authors:  Xiefeng Wang; Lili Huang; Yanjie Xu; Zhumei Shi; Yingyi Wang; Junxia Zhang; Xirui Wang; Lei Cao; Hui Luo; Jiawei Chen; Ning Liu; Yongmei Yin; Yongping You
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

Review 2.  ErbB receptors: from oncogenes to targeted cancer therapies.

Authors:  Hongtao Zhang; Alan Berezov; Qiang Wang; Geng Zhang; Jeffrey Drebin; Ramachandran Murali; Mark I Greene
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

3.  Differential requirements for survivin in hematopoietic cell development.

Authors:  Sandeep Gurbuxani; Yanfei Xu; Ganesan Keerthivasan; Amittha Wickrema; John D Crispino
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-29       Impact factor: 11.205

Review 4.  Survivin at a glance.

Authors:  Sally P Wheatley; Dario C Altieri
Journal:  J Cell Sci       Date:  2019-04-04       Impact factor: 5.285

5.  The role of survivin in diagnosis, prognosis and treatment of breast cancer.

Authors:  Yong-Gang Lv; Fang Yu; Qing Yao; Jiang-Hao Chen; Ling Wang
Journal:  J Thorac Dis       Date:  2010-06       Impact factor: 2.895

6.  Structural basis for recognition of H3T3ph and Smac/DIABLO N-terminal peptides by human Survivin.

Authors:  Jiamu Du; Alexander E Kelly; Hironori Funabiki; Dinshaw J Patel
Journal:  Structure       Date:  2012-01-11       Impact factor: 5.006

7.  Functional analysis of a survivin-like gene in Bombyx mori.

Authors:  Hui Tang; Yu Wu; Haixiang Wu; Yan Wu; Huiling Wu; Wenbing Wang
Journal:  Cytotechnology       Date:  2013-03-26       Impact factor: 2.058

8.  Significance and relationship between Yes-associated protein and survivin expression in gastric carcinoma and precancerous lesions.

Authors:  Chun-Li Da; Yan Xin; Jing Zhao; Xiang-Dong Luo
Journal:  World J Gastroenterol       Date:  2009-08-28       Impact factor: 5.742

9.  Chemically synthesized human survivin does not inhibit caspase-3.

Authors:  Changqing Li; Zhibin Wu; Min Liu; Marzena Pazgier; Wuyuan Lu
Journal:  Protein Sci       Date:  2008-06-06       Impact factor: 6.725

10.  A survivin-ran complex regulates spindle formation in tumor cells.

Authors:  Fang Xia; Pedro M Canovas; Thomas M Guadagno; Dario C Altieri
Journal:  Mol Cell Biol       Date:  2008-06-30       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.